2-Methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)aniline

2-Methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)aniline is an organic substance that is a cycloalkylamine analogue used as an intermediate in organic synthesis, particularly in the synthesis of the anticancer drug Brigatinib, which inhibits epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK).